scanX
Zydus Life Science
add_icon

Zydus Life Science

1,089.00
+4.40
(0.41%)
Market Cap
1,09,578.88 Cr
PE Ratio
21.32
Volume
9,19,205.00
Day High - Low
1,097.00 - 1,082.20
52W High-Low
1,115.50 - 835.50
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,09,578.88 Cr
EPS
50.09
PE Ratio
21.32
PB Ratio
4.03
Book Value
269.43
EBITDA
7,529.80
Dividend Yield
0.09 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
17.51
Debt to Equity
0.09
Analyst Rating and Forecast
- By Refinitiv from29 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+48.28 %
+48.28 %
Hold
Hold+34.48 %
+34.48 %
Sell
Sell+17.24 %
+17.24 %
Forecast For
Actual

Company News

View All News
Caret
negative
Zydus Lifesciences Gets USFDA Warning Letter for Baddi Facility3 days ago
Zydus Lifesciences received a USFDA warning letter for its Baddi facility over purified talc not meeting USP standards; current operations and supplies remain unaffected.
positive
Zydus Lifesciences Gets US FDA Priority Review for Saroglitazar NDA10 days ago
Zydus Lifesciences has received US FDA Priority Review for its New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC).
neutral
Zydus Lifesciences discloses share transmissionMay 26, 2026
Zydus Lifesciences disclosed the transmission of 10,000 equity shares from a deceased promoter group member to Mr. Samar Babubhai Patel. The transaction was off-market and intimated to the company on May 25, 2026.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,782.20
#1 4,27,609.48
37.09
#1 58,220.10
6.38
#1 11,565
25.80
43.33
Divis Laboratories
6,623.00
1,75,819.84
68.17
10,560.00
8.73
2,520
13.44
49.66
Torrent Pharmaceuticals
4,420.90
1,49,623.34
68.66
13,886.20
20.34
2,138
-26.91
53.32
Cipla
1,401.30
1,13,194.31
29.24
27,711.70
-2.46
3,783
-55.32
58.57
Zydus Life Science
1,089.00
#5 1,09,578.88
#2 21.32
#6 26,719.70
#4 13.65
#3 5,242
#6 7.82
71.01
Dr Reddys Laboratories
1,278.20
1,06,684.07
25.44
33,593.30
-0.44
3,998
-86.05
45.82
Lupin
2,267.70
1,03,643.69
#1 19.20
27,487.50
19.98
5,345
#1 87.72
47.04
Mankind Pharma
2,336.10
96,435.39
50.16
14,277.60
12.03
1,750
31.75
47.08
Aurobindo Pharma
1,462.30
84,930.62
24.27
33,384.70
3.21
3,376
1.99
53.78
Laurus Labs
1,446.80
78,106.45
86.55
6,812.90
#1 21.03
884
21.18
80.98

Automatic Screeners on ScanX

Community
2% near 52 Week High
Growth Rate
Revenue Growth
13.65 %
Net Income Growth
13.58 %
Cash Flow Change
109.94 %
ROE
0.98 %
ROCE
7.64 %
EBITDA Margin (Avg.)
-11.29 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
2,269
2,291
2,286
2,300
2,310
2,232
2,360
2,266
2,479
2,127
3,165
3,206
3,197
2,870
2,875
3,547
3,658
3,429
3,271
3,555
3,672
3,462
3,663
3,645
3,551
3,971
6,106
3,590
3,821
3,989
3,993
4,199
4,890
5,089
4,313
4,403
5,526
6,110
5,182
5,181
6,371
6,622
6,147
6,892
7,569
Expenses
1,792
1,807
1,740
1,768
1,784
1,763
1,841
1,907
2,004
1,909
2,365
2,404
2,399
2,249
2,273
2,738
2,932
2,864
3,009
2,947
3,013
2,724
2,977
2,867
2,916
3,092
2,860
2,895
3,103
3,251
3,319
3,301
4,359
3,650
3,224
3,403
3,903
4,124
3,776
3,882
4,622
4,485
4,142
5,133
5,430
EBITDA
477
484
546
532
526
468
519
359
476
218
800
802
798
621
601
809
726
565
262
608
658
738
686
779
635
879
3,246
695
718
738
673
898
532
1,439
1,089
1,000
1,623
1,986
1,407
1,299
1,749
2,137
2,005
1,759
2,139
Operating Profit %
20 %
20 %
23 %
22 %
21 %
20 %
21 %
15 %
17 %
9 %
25 %
24 %
24 %
19 %
20 %
22 %
19 %
16 %
7 %
17 %
17 %
20 %
17 %
20 %
19 %
21 %
22 %
18 %
17 %
17 %
16 %
21 %
10 %
28 %
24 %
22 %
27 %
32 %
26 %
24 %
27 %
31 %
31 %
24 %
27 %
Depreciation
76
69
73
74
76
84
86
90
114
122
126
147
144
142
148
154
156
172
172
174
179
173
175
176
175
183
177
177
185
181
182
182
179
180
184
195
205
215
234
229
238
238
302
360
508
Interest
16
12
13
12
16
14
15
7
10
22
41
13
15
35
36
46
77
89
90
81
83
68
45
27
23
27
30
31
39
34
35
33
28
18
9
20
35
32
25
32
77
85
101
130
123
Profit Before Tax
426
519
545
537
498
441
435
324
412
154
712
722
724
570
535
672
606
394
122
457
522
588
524
617
526
777
3,135
598
558
673
648
781
484
1,328
1,006
947
1,550
1,900
1,271
1,184
1,672
1,921
1,687
1,353
1,660
Tax
69
51
60
97
-74
36
46
-6
20
9
200
168
125
102
107
150
124
69
28
86
108
102
89
89
-210
135
123
87
105
96
122
149
125
195
203
157
304
417
351
158
428
400
449
331
319
Net Profit
357
468
485
440
572
405
389
331
393
145
513
553
599
467
428
522
482
325
94
371
414
487
435
528
735
643
3,012
511
453
576
526
631
358
1,134
803
790
1,246
1,483
920
1,026
1,244
1,521
1,239
1,023
1,341
EPS in ₹
17.11
22.47
6.46
4.21
5.59
3.89
3.71
3.16
3.77
1.35
4.92
5.31
5.77
4.50
4.08
4.99
4.40
2.97
1.05
3.65
3.83
4.43
4.62
5.15
6.64
5.74
29.32
4.89
3.88
5.06
5.15
6.15
2.93
10.74
7.91
7.80
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
12.65
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
9,047
10,551
15,221
18,065
23,483
23,687
23,885
27,795
25,756
29,281
37,202
52,407
Fixed Assets
3,352
3,748
5,755
6,483
12,164
12,231
12,133
12,189
11,521
12,369
13,134
20,262
Current Assets
4,227
4,280
6,022
8,230
8,498
8,715
8,716
12,095
10,008
11,420
17,046
19,906
Capital Work in Progress
798
951
1,543
1,527
837
742
783
726
1,201
2,423
2,692
1,166
Investments
121
416
435
746
674
765
830
3,288
1,547
1,221
6,408
5,628
Other Assets
4,776
5,436
7,488
9,310
9,809
9,950
10,139
11,593
11,488
13,269
14,968
0
Total Equity & Liabilities
9,047
10,551
15,221
18,065
23,483
23,687
23,885
27,795
25,756
29,281
37,202
52,407
Current Liabilities
3,285
3,461
5,306
6,083
7,343
8,269
7,861
7,827
5,527
5,340
9,042
15,712
Non Current Liabilities
1,342
1,255
2,799
3,047
4,461
3,707
1,094
915
541
1,840
1,802
7,113
Total Equity
4,421
5,835
7,116
8,936
11,679
11,710
14,930
19,054
19,688
22,102
26,358
27,111
Reserve & Surplus
4,149
5,597
6,858
8,642
10,284
10,273
12,890
16,897
17,415
19,729
23,853
27,011
Share Capital
102
102
102
102
102
102
102
102
101
101
101
101
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
178
99
756
-3
-811
399
-91
2,373
-534
-75
414
Investing Activities
-465
-860
-2,872
-974
-3,977
-1,012
-835
1,137
1,178
-1,492
-8,377
Operating Activities
994
1,894
1,312
919
1,282
2,505
3,293
2,104
2,689
3,228
6,777
Financing Activities
-351
-935
2,316
52
1,885
-1,094
-2,549
-868
-4,400
-1,810
2,014
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
74.88 %
74.88 %
74.88 %
74.88 %
74.88 %
74.88 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.99 %
74.99 %
74.99 %
75.00 %
75.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.72 %
5.59 %
7.52 %
7.53 %
7.32 %
7.13 %
7.34 %
7.06 %
6.95 %
DIIs
11.11 %
10.43 %
11.22 %
11.78 %
12.78 %
11.92 %
12.94 %
13.69 %
13.60 %
13.23 %
13.09 %
12.79 %
12.63 %
12.64 %
10.65 %
10.65 %
11.01 %
11.13 %
10.86 %
11.09 %
11.20 %
Government
0.19 %
0.07 %
0.07 %
0.07 %
0.08 %
0.08 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
6.16 %
7.31 %
7.38 %
7.40 %
7.81 %
8.02 %
7.60 %
7.04 %
6.42 %
5.97 %
5.67 %
5.60 %
5.29 %
5.37 %
5.48 %
5.47 %
5.41 %
5.46 %
5.49 %
5.54 %
5.54 %
Others
7.66 %
7.32 %
6.44 %
5.87 %
4.46 %
5.11 %
4.48 %
4.29 %
5.00 %
5.82 %
6.26 %
6.63 %
1.38 %
1.43 %
1.37 %
1.36 %
1.28 %
1.28 %
1.32 %
1.31 %
1.32 %
No of Share Holders
0
2,23,384
3,31,155
3,51,595
3,70,931
4,08,017
4,55,624
4,08,231
3,70,396
3,11,764
2,97,953
3,06,495
2,94,324
3,36,309
3,70,863
3,65,356
3,71,619
3,86,127
3,96,105
4,03,266
4,18,314

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 3.2 3.5 3.5 3.5 3.5 2.5 6 3 11 0.00
Dividend Yield (%) 0.85 1.01 1.31 0.79 1 0.51 0.6 0.34 1.26 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
 11 Aug 2026 991.10 1,088.90
24 Jul 2026 DIVIDEND Dividend
₹ 1.00 /share
 24 Jul 2026 991.10 1,088.90
30 Jul 2021 DIVIDEND Dividend
₹ 3.50 /share
 28 Jul 2021 628.10 571.90
29 Jul 2022 DIVIDEND Dividend
₹ 2.50 /share
 28 Jul 2022 338.75 349.60
28 Jul 2023 DIVIDEND Dividend
₹ 6.00 /share
 28 Jul 2023 518.80 649.50
29 Feb 2024 BUYBACK Buyback
1005
 23 Feb 2024 953.75 932.80
26 Jul 2024 DIVIDEND Dividend
₹ 3.00 /share
 26 Jul 2024 1,009.00 1,205.80
09 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 09 Aug 2024 1,009.00 1,279.40
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Nov 2024 1,002.20 968.55
05 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 05 Feb 2025 995.50 974.00
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 20 May 2025 873.70 911.40
25 Jul 2025 DIVIDEND Dividend
₹ 11.00 /share
 25 Jul 2025 902.70 971.05
12 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 12 Aug 2025 911.40 955.50
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Aug 2025 969.80 955.50
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 06 Nov 2025 1,001.35 971.70
09 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 09 Feb 2026 881.95 887.85
19 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 19 May 2026 940.10 991.10
04 Jun 2026 BUYBACK Buyback
1260
 29 May 2026 1,088.90 1,076.45

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20153 days ago
Corporate Action-Updates on Buy back5 days ago
Corporate Action-Updates on Buy back6 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release9 days ago
Corporate Action-Updates on Buy back9 days ago
Corporate Action-Updates on Buy back10 days ago
Update10 days ago
Disclosure Under SEBI (Prohibition Of Insider Trading) Regulations 2015May 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2026
Corporate Action-Updates on Buy backMay 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 20, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 20, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 20, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 20, 2026
Corporate Action-Updates on Buy backMay 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 19, 2026
Corporate Action-Updates on Buy backMay 19, 2026
General Update On BuybackMay 19, 2026
Record Date For Buy BackMay 19, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 19, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 19, 2026
Record Date For Dividend July 24 2026May 19, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 19, 2026
Corporate Action-Buy backMay 19, 2026
Corporate Action-Board approves DividendMay 19, 2026
Board Meeting Outcome for Audited Financial Results For The Quarter / Year Ended On March 31 2026May 19, 2026
Audited Financial Results For The Quarter / Year Ended On March 31 2026May 19, 2026
Announcement under Regulation 30 (LODR)-AcquisitionMay 13, 2026
Receipt Of Demand Order-In-Appeal From Appellate Authority Central Goods And Services Tax Appeals Commissionerate ChandigarhMay 13, 2026
Update on board meetingMay 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2026
Announcement under Regulation 30 (LODR)-CessationMay 13, 2026
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter / Year Ended On March 31 2026May 08, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 06, 2026
Receipt Of Demand Order-In-Original From Deputy Commissioner Of CGST & Central Excise Ahmedabad North CommissionerateMay 05, 2026
Announcement under Regulation 30 (LODR)-AcquisitionMay 01, 2026
Announcement under Regulation 30 (LODR)-AcquisitionMay 01, 2026
Incorporation Of A Wholly Owned Subsidiary In The United States Of AmericaApr 30, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 25, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 22, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 22, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 16, 2026
Update On GST OrderApr 15, 2026
ESG RatingApr 10, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 08, 2026
Intimation Of Drop In GST DemandApr 07, 2026
Intimation Of Drop In GST DemandApr 06, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Samco Large & Mid Cap Fund Direct-Growth
0.00%
-55800
-4.35%
0.00%
Old Bridge Flexi Cap Fund Direct-Growth
2.57%
44000
2.57%
2.57%
Sundaram Multi-Factor Fund Direct-Growth
2.20%
-3693
-0.19%
0.01%
Capitalmind Multi Asset Allocation Fund Direct-Growth
2.25%
2512
0.02%
2.25%
Parag Parikh Large Cap Fund Direct-Growth
0.16%
2064
-0.01%
-0.01%
Bandhan Multi-Factor Fund Direct-Growth
0.80%
1792
-0.05%
0.14%
Choice Nifty Next 50 Index Fund Direct-Growth
0.90%
1166
0.90%
0.90%
Tata Nifty Next 50 Index Fund Direct-Growth
0.91%
433
-0.10%
-0.08%
JioBlackRock Nifty Next 50 Index Fund Direct-Growth
0.91%
-389
-0.11%
-0.08%
DSP Nifty Healthcare Index Fund Direct-Growth
2.21%
379
-0.05%
-0.09%
UTI Nifty500 Shariah Index Fund Direct-Growth
0.40%
364
-0.02%
-0.01%
Edelweiss Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.06%
269
0.06%
0.06%
JioBlackRock Sector Rotation Fund Direct-Growth
0.15%
210
-0.01%
-0.01%
Nippon India Nifty India Manufacturing Index Fund Direct-Growth
0.58%
114
-0.04%
-0.02%
Zerodha Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.06%
93
0.06%
0.06%
Nippon India Nifty 500 Low Volatility 50 Index Fund Direct-Growth
0.76%
60
-0.04%
0.00%
Groww Nifty Next 50 Index Fund Direct-Growth
0.90%
52
-0.11%
-0.09%
Bajaj Finserv Nifty Next 50 Index Fund Direct-Growth
0.90%
42
-0.12%
-0.09%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.11%
28
-0.01%
0.00%
DSP Nifty 500 Index Fund Direct-Growth
0.11%
14
-0.01%
-0.01%
ICICI Prudential Regular Savings Fund Direct-Growth
0.00%
0
0.00%
0.00%
Kotak Equity Savings Fund Direct-Growth
0.02%
0
0.00%
0.00%
Baroda BNP Paribas Business Conglomerates Fund Direct-Growth
1.30%
0
-0.09%
0.02%
Baroda BNP Paribas Midcap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Value Fund Direct-Growth
1.52%
0
0.00%
-0.09%

Technical Indicators

RSI(14)
Neutral
71.01
ATR(14)
Less Volatile
29.15
STOCH(9,6)
Neutral
64.35
STOCH RSI(14)
Neutral
56.74
MACD(12,26)
Bullish
1.91
ADX(14)
Very Strong Trend
50.46
UO(9)
Bearish
51.66
ROC(12)
Uptrend And Accelerating
6.88
WillR(14)
Neutral
-20.76
Bearish
4
Neutral
3
Bullish
2

About Zydus Life Science

Zydus Lifesciences Limited is an Indian global life sciences company that discovers, develops, manufactures, and markets healthcare therapies. Its product portfolio includes active pharmaceutical ingredients, human formulations, animal health products, and wellness products. The company operates in pharmaceuticals, covering human and veterinary formulations, bulk drugs, diagnostics, herbal products, skin care,...more
Listing Date
27 Apr, 2000(26 Years, -21 days)
Website
https://www.zyduscadila.com
Chairperson NamePankaj R Patel
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104